golimumba ANd acute exaberation of Anylosing spondylitis
Answers
Answered by
0
Golimumab is a human IgG monoclonal antibody specific for human tumor necrosis factor alpha. Golimumab has been approved for use in rheumatological conditions; however, its use in inflammatory bowel disease is still being evaluated in clinical trials. We report a case of an exacerbation of ulcerative proctitis after starting on golimumab for ankylosing spondylitis.
HOPE IT'S HELP YOU
HOPE IT'S HELP YOU
Similar questions